US Market Research

US Market Research

Pitter. Patter. Splatter.

Monday July 6, 2026

Jul 06, 2026
∙ Paid

Right now retail is in a frenzy over three stocks. Abivax, Nektar and Sellas. The first two retail completely missed before the data came out the last one retail have been pushing up the price leading into data.

Abivax is up ~1600% after releasing data that is best in disease. Sellas is up ~1600% before releasing data. There is inherently less risk in riding a stock into data than holding through data and praying. So why not find those stocks? Or at least look for them.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Gravity Analytica Capital LLC · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture